Pervasive Child Development Disorders

Subscribe to Selected New Research on Pervasive Child Development Disorders

3 relevant articles (0 outcomes, 1 trials/studies) found for this Disease

Description: Severe distortions in the development of many basic psychological functions that are not normal for any stage in development. These distortions are manifested in sustained social impairment, speech abnormalities, and peculiar motor movements.

Also Known As:

Child Development Disorders, Pervasive; Development Disorder, Pervasive; Development Disorders, Pervasive; Disorder, Pervasive Development; Disorders, Pervasive Development; Pervasive Development Disorder; Pervasive Development Disorders

Disease Context: Research Results

Mental Disorders: 1709

Mental Disorders Diagnosed in Childhood

Pervasive Child Development Disorders: 3

Autistic Disorder: 1861

Rett Syndrome: 449

Asperger Syndrome: 66

Childhood Schizophrenia: 31

Related Diseases

1.	Mental Retardation (Idiocy)
2.	Syndrome
3.	Cerebral Palsy (Spastic Diplegia)
4.	Autistic Disorder (Autism)

Experts

1.	Shea, Sarah E: 1 article (05/2006)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Pervasive Child Development Disorders:

1.	Tuberculin (PPD)IBA 01/01/2007 - "Aims of the present study were: to evaluate QOL in parents of children affected by Pervasive Development Disorder (PDDs), Cerebral Palsy (CP) or Mental Retardation (MR) as compared to a control group (CG); to evaluate QOL of parents of patients with different types of PDDs, namely Autistic Disorder (AD), High Function Autism/Asperger Syndromes (HFA/AS) and Pervasive Developmental Disorder Not Otherwise Specified (PPD-NOS); and to compare the level of impairment in QOL of mothers and fathers within PDDs, CP, MR groups and between AD, HFA/AS, PDD-NOS sub-groups" Order ALL the reference details at left...
2.	Antipsychotic Agents (Antipsychotics)IBA 08/01/2006 - "In contrast, administration of prn sedation was associated with multiple diagnoses (p < 0.01), pervasive development disorder (p < 0.01), mental retardation (p < 0.01) ADHD (p < 0.01), longer hospital admission (p < 0.01), use of atypical antipsychotics (p < 0.01) and polypharmacy (p < 0.01)" Order ALL the reference details at left...
3.	Methylphenidate (Ritalin)FDA LinkGeneric 05/01/2006 - "Methylphenidate hydrochloride reduces hyperactivity in children with pervasive development disorders." Order ALL the reference details at left...

Therapies and Procedures

1.	Polypharmacy 08/01/2006 - "In contrast, administration of prn sedation was associated with multiple diagnoses (p < 0.01), pervasive development disorder (p < 0.01), mental retardation (p < 0.01) ADHD (p < 0.01), longer hospital admission (p < 0.01), use of atypical antipsychotics (p < 0.01) and polypharmacy (p < 0.01)" Order ALL the reference details at left...

Best Treatments:
Research Summary Report
on Pervasive Child Development Disorders

*WARNING* This specific disease subtype has a relatively small number of significant evidence outcomes. You may proceed to order anyway, or go back to the search field and enter a more general type of the target illness. Once your report has been ordered, however, we can't refund the purchase.

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.

Free Updates for 1 Year
All 0 Outcomes
Top 200 Key Drugs and Biologics
Top 50 Key Therapies and Procedures
Detailed History Charts
Full Research Reference Details
Sample PDF Report on Psoriasis >>

Price:

$24.00 & Delivery via PDF download
updates for 1 year

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License Details >>

Price:

$490.00 access via web interface
1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m"
1 year subscription

Proceed to Checkout >>